NanoViricides

NanoViricides raises $5M in shelf offering

Monday, July 2, 2012

NanoViricides, a West Haven, Conn.-based development stage company that creates special purpose nanomaterials for antiviral therapy, has raised $5 million drawing down on its previously announced universal registered shelf “Form S-3” offering. The registered shelf offering became effective on April 29, 2010, and continues to remain effective.

[Read More]